Article Menu
Need Help?
No Article Versions Notes Found
Cite
Telfer, P.; Agodoa, I.; Fox, K.M.; Burke, L.; Mant, T.; Jurek, M.; Tonda, M.; Lehrer-Graiwer, J. Impact of Voxelotor (GBT440) on Unconjugated Bilirubin and Jaundice in Sickle Cell Disease. Hematol. Rep. 2018, 10, 7643. https://doi.org/10.4081/hr.2018.7643
Telfer P, Agodoa I, Fox KM, Burke L, Mant T, Jurek M, Tonda M, Lehrer-Graiwer J. Impact of Voxelotor (GBT440) on Unconjugated Bilirubin and Jaundice in Sickle Cell Disease. Hematology Reports. 2018; 10(2):7643. https://doi.org/10.4081/hr.2018.7643
Chicago/Turabian StyleTelfer, Paul, Irene Agodoa, Kathleen M. Fox, Laurie Burke, Timothy Mant, Marzena Jurek, Margaret Tonda, and Josh Lehrer-Graiwer. 2018. "Impact of Voxelotor (GBT440) on Unconjugated Bilirubin and Jaundice in Sickle Cell Disease" Hematology Reports 10, no. 2: 7643. https://doi.org/10.4081/hr.2018.7643
APA StyleTelfer, P., Agodoa, I., Fox, K. M., Burke, L., Mant, T., Jurek, M., Tonda, M., & Lehrer-Graiwer, J. (2018). Impact of Voxelotor (GBT440) on Unconjugated Bilirubin and Jaundice in Sickle Cell Disease. Hematology Reports, 10(2), 7643. https://doi.org/10.4081/hr.2018.7643
